Course Code: TC-GMP-CAPA-08 | Version: 1.0 | Duration: 4.5 hours | Level: Intermediate to Advanced
Course Overview
CAPA — Corrective and Preventive Action — is one of the most scrutinised elements of any pharmaceutical quality management system. It is the mechanism by which a GMP organisation demonstrates that it learns from its failures, addresses their root causes, prevents their recurrence, and identifies potential problems before they occur. A functioning CAPA system is the clearest evidence of a mature quality culture. A dysfunctional one — characterised by late closures, superficial root cause analysis, symptomatic corrective actions, and absent effectiveness verification — is one of the most common and most damaging findings in health authority inspections and client audits globally.
The paradox of CAPA is this: most organisations have CAPA systems. Most produce CAPA documentation. But in a significant proportion of regulated facilities, that documentation describes a process that either does not happen at the required depth, or happens on paper while the actual quality problem continues unremediated. A CAPA log with 40 open items and 60% overdue is not a quality management tool — it is a record of unaddressed quality risk. A CAPA that closes a deviation by retraining an operator without investigating why the system allowed the deviation to occur is not a corrective action. It is a documentation exercise that leaves the quality problem intact, ready to generate the next failure.
This course builds genuine CAPA capability — from the regulatory foundations and quality system architecture through structured root cause analysis tools, precise CAPA action plan writing, rigorous effectiveness verification design, CAPA trending and metrics, and the management oversight that makes a CAPA system function as a quality protection mechanism rather than compliance paperwork. Every lesson is built around the one question that should drive every CAPA: not 'How do we close this record?' but 'How do we ensure this never happens again?'
Learning Objectives
On completion, learners will be able to:
- Explain the regulatory framework governing CAPA under EU GMP Chapter 1, ICH Q10, FDA 21 CFR 211.192, FDA CAPA guidance (2014), and ISO 13485 Clause 8.5
- Distinguish between corrective action, preventive action, and containment — and explain why confusing them is one of the most common CAPA failures
- Describe the eight-stage CAPA lifecycle and identify the stages most frequently skipped or inadequately executed
- Apply structured root cause analysis tools — 5 Whys, fishbone (Ishikawa) diagram, and fault tree analysis — to realistic GMP quality events
- Identify and avoid the seven most common root cause analysis failures, including stopping at the direct cause, confirmation bias, and scope narrowing
- Write CAPA action plans that address root causes at the systemic level, using specific, accountable, time-bound actions with defined deliverables
- Design effective CAPA effectiveness verification plans with defined acceptance criteria, named verifiers, and specific completion timelines
- Manage CAPA timelines, priorities, escalations, and extensions within a functioning quality management system
- Use CAPA trend analysis to identify systemic quality risks, measure system performance, and drive proactive quality improvement
- Describe the management oversight responsibilities for CAPA — including CAPA board governance, management review integration, and quality culture indicators
Audience
QA managers, QA associates, CAPA owners, deviation investigators, production supervisors, QC managers, QPs, regulatory affairs
